AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 99.50
+0.10 (0.10%)
Aug 19, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 9.64 billion as of August 18, 2026. Its market cap has decreased by -8.65% in one year.
Market Cap
9.64B
Enterprise Value
7.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
99.50
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 9.64B, an increase of 89.20%. That is a compound annual growth rate of 22.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 9.64B | -37.07% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ever Supreme Bio Technology | 14.96B |
| Lumosa Therapeutics | 14.42B |
| ACRO Biomedical | 12.46B |
| Gongwin Biopharm Holdings | 12.24B |
| Tanvex BioPharma | 9.98B |
| Polaris Group | 9.42B |
| TCM Biotech International | 9.00B |
| PharmaEngine | 8.92B |